A smartphone-based electrocardiogram (ECG) screening accurately detected previously unknown atrial fibrillation in American Indians, and more than half who were diagnosed with the irregular heart ...
Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism (blood clot) in older adults aged 75-76 years over 5 years ...
Please provide your email address to receive an email when new articles are posted on . The AMALFI trial evaluated a completely remote approach to atrial fibrillation screening. Remote screening with ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
MOUNTAIN VIEW, Calif., Jan. 7, 2022 /PRNewswire/ -- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the National Institute for Health and ...
HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...
MADRID — A simple home-based screening strategy that involved wearing an ECG patch for 14 days increased the diagnosis of atrial fibrillation (AF) and associated use of anticoagulants in patients at ...
The correct diagnosis is atrial fibrillation with PVC and Ashman phenomenon (Figure 2). The rhythm is irregularly irregular without any organized atrial activity. Most of the QRS complexes are narrow, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results